The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

被引:19
|
作者
Fu, Wing-Yu [1 ,2 ]
Ip, Nancy Y. [1 ,2 ,3 ]
机构
[1] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, State Key Lab Mol Neurosci,Clear Water Bay,Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Shenzhen Hong Kong Inst Brain Sci, HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen 518057, Guangdong, Peoples R China
关键词
Synapses; Genetic risks; Synaptic vesicles; Neurotransmitter release; Neurotransmission; Synaptic plasticity; Protein trafficking; GENOME-WIDE ASSOCIATION; APOE GENOTYPE; RECEPTOR FUNCTION; PROTEIN CD2AP; PLASTICITY; ADAM10; TREM2; BETA; PHOSPHORYLATION; MUTATIONS;
D O I
10.1016/j.semcdb.2022.07.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions. Due to the extended global life expectancy, the prevalence of AD is increasing among aging populations worldwide. While AD is a multifactorial disease, synaptic dysfunction is one of the major neuro-pathological changes that occur early in AD, before clinical symptoms appear, and is associated with the pro-gression of cognitive deterioration. However, the underlying pathological mechanisms leading to this synaptic dysfunction remains unclear. Recent large-scale genomic analyses have identified more than 40 genetic risk factors that are associated with AD. In this review, we discuss the functional roles of these genes in synapto-genesis and synaptic functions under physiological conditions, and how their functions are dysregulated in AD. This will provide insights into the contributions of these encoded proteins to synaptic dysfunction during AD pathogenesis.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [31] Genetic Risk Factors for Depression in Alzheimer's Disease Patients
    Arlt, Soenke
    Demiralay, Cueneyt
    Tharun, Bjoern
    Geisel, Olga
    Storm, Niels
    Eichenlaub, Martin
    Lehmbeck, Jan T.
    Wiedemann, Klaus
    Leuenberger, Boris
    Jahn, Holger
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (01) : 72 - 81
  • [32] Search for modifying factors in the genetic risk of Alzheimer's disease
    Scharfetter, C
    Hell, D
    Stassen, HH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 615 - 615
  • [33] Genetic and environmental risk factors for Alzheimer's disease.
    Mayeux, R
    Launer, L
    Yaffe, K
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s101 - s101
  • [34] Influence of genetic and cardiometabolic risk factors in Alzheimer?s disease
    Pasqualetti, Giuseppe
    Thayanandan, Tony
    Edison, Paul
    AGEING RESEARCH REVIEWS, 2022, 81
  • [35] Alzheimer's disease: Identification of genes and genetic risk factors
    Van Broeckhoven, C
    NEURONAL DEGENERATION AND REGENERATION: FROM BASIC MECHANISMS TO PROSPECTS FOR THERAPY, 1998, 117 : 315 - 325
  • [36] Genetic risk factors for Alzheimer's disease in African Americans
    Murray, MM
    Clark, RF
    NEUROBIOLOGY OF AGING, 2004, 25 : S486 - S486
  • [37] Silibinin's role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer's disease models
    Zhang, Baohui
    Zhang, Di
    Chen, Keyan
    Wu, Tengfei
    APOPTOSIS, 2025, : 861 - 879
  • [38] Role of extracellular vesicles released by microglia in early synaptic dysfunction in Alzheimer's disease
    Gabrielli, M.
    Joshi, P.
    Rutigliano, G.
    Lombardi, M.
    Arancio, O.
    Origlia, N.
    Verderio, C.
    GLIA, 2019, 67 : E256 - E257
  • [39] The role of synaptic microRNAs in Alzheimer's disease
    Kumar, Subodh
    Reddy, P. Hemachandra
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (12):
  • [40] The role of synaptic proteins in Alzheimer's disease
    Masliah, E
    ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 68 - 75